DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Anthem Biosciences Limited — Investor Presentation

NSE 5 hrs ago·21 Jul 2026, 11:08 am

Anthem Biosciences

Anthem Biosciences Limited has submitted its investor presentation to the stock exchanges. This document typically outlines the company's current business performance, future growth strategies, and operational outlook for the upcoming period.

For investors, this update is a key opportunity to understand the management's perspective on market conditions and the company's trajectory. It provides transparency into the company's direction and helps retail investors assess its competitive position and potential for growth.

Investors should watch for details regarding the company's revenue projections, expansion plans, and any commentary on the broader industry trends. This information will be crucial for evaluating the stock's future performance.